Pulmonary Angioplasty Without Anticoagulants May Reduce the Rate of Hemoptysis and Make the Procedure Safer

Ferrari, Émile; Labbaoui, Mohamed; Moceri, Pamela; Baudouy, Delphine; Leroy, Sylvie; Taniguchi, Yu

doi:10.1016/s0735-1097(20)32727-3

Cited by 2 publications

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The complication incidence was low with only one minor spontaneously resolving hemoptysis. As previously described, our procedures were done after stopping anticoagulant therapy [17] which might have helped controlling hemoptysis.…”

Section: Resultsmentioning

confidence: 99%

“…Out of 81 procedures, sPAP before and after procedures was: 65 mmHg [59-74] vs 75 mm Hg [64-80] P =0.005; mPAP was 38 mmHg [33-43] vs 43 mmHg [36-48] P <0.001; dPAP was 23 mmHg [17][18][19][20][21][22][23][24][25][26][27] vs 24 mmHg [20][21][22][23][24][25][26]: P =0.3. In all, PAP rose in 81% of the procedures (Table 2).…”

Section: Resultsmentioning

confidence: 99%

“…Oral anticoagulation, mainly non-vitamin K antagonist oral anticoagulants: Rivaroxaban or Apixaban which are our chosen anticoagulation option in CTEPH, was discontinued 36 hours before each procedure [17]. The majority of patients did not need cardiology intensive care unit monitoring and returned to their cardiology ward.…”

Section: Bpa Procedures and Right Heart Catheterizationmentioning

confidence: 99%

See 2 more Smart Citations

Paradoxical rise in pulmonary pressures and BNP immediately after balloon pulmonary angioplasty for CTEPH

Ferrari

Fourrier

Yanaka

et al. 2023

Archives of Cardiovascular Diseases Supplements

View full text Add to dashboard Cite

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Bpa Procedures and Right Heart Catheterizationmentioning

confidence: 99%

See 1 more Smart Citation

Paradoxical rise in pulmonary pressures and BNP immediately after balloon pulmonary angioplasty for CTEPH

Ferrari

Fourrier

Yanaka

et al. 2023

Archives of Cardiovascular Diseases Supplements

View full text Add to dashboard Cite

Changes in Inflammatory Markers in Patients with Chronic Thromboembolic Pulmonary Hypertension Treated with Balloon Pulmonary Angioplasty

Magoń

Stępniewski

Waligóra

et al. 2022

Cells

View full text Add to dashboard Cite

Background: Inflammatory response and endothelial dysfunction contribute to the progression of chronic thromboembolic pulmonary hypertension (CTEPH). We aimed to assess changes in biomarkers involved in those processes in inoperable CTEPH patients treated with balloon pulmonary angioplasty (BPA). Methods: We enrolled 20 patients with inoperable CTEPH qualified for BPA and a control group. Interleukin 6, 8, 10 (IL-6, IL-8, IL-10), monocyte chemoattractant protein-1 (MCP-1), and C-reactive protein (hsCRP) constituted the markers of systemic inflammation. Endothelin 1 (ET-1) served as a marker of endothelial dysfunction. Selected markers were assessed before the BPA treatment, 24 h after the first BPA, and six months after completion of the BPA treatment. Results: At baseline, the CTEPH patients had increased serum concentrations of IL-6, IL-8 and ET-1. Twenty-four hours after a BPA session, we observed an increase in concentrations of IL-6 (∆ = 3.67 (1.41; 7.16); p < 0.001), of IL-10 (∆ = 0.25 (0; 0.47); p = 0.003), of MCP-1 (∆ = 111 (60.1; 202.8); p = 0.002), and of hsCRP (∆ = 4.81 (3.46; 8.47); p < 0.001). Six months after completion of the BPA treatment, there was a decrease in concentrations of IL-6 (∆ = −1.61 (−3.11; −0.20); p = 0.03), of IL8 (∆ = −3.24 (−7.72; 0.82); p = 0.01), and of ET-1 (∆ = −0.47 (−0.96; 0.05); p = 0.005). Conclusions: Patients with inoperable CTEPH exhibit increased systemic inflammation and endothelial dysfunction, which improves after completion of the BPA treatment. A single BPA session evokes an acute inflammatory response.

show abstract

Pulmonary Angioplasty Without Anticoagulants May Reduce the Rate of Hemoptysis and Make the Procedure Safer

Cited by 2 publications

References 0 publications

Paradoxical rise in pulmonary pressures and BNP immediately after balloon pulmonary angioplasty for CTEPH

Paradoxical rise in pulmonary pressures and BNP immediately after balloon pulmonary angioplasty for CTEPH

Changes in Inflammatory Markers in Patients with Chronic Thromboembolic Pulmonary Hypertension Treated with Balloon Pulmonary Angioplasty

Contact Info

Product

Resources

About